Comparison the Effect of Quetiapine and Haloperidol on the Treatment of ?delirium in ICU

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180911040998N1

Enrollment

Registered

2018-10-31

Start date

2018-02-04

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium. Delirium due to known physiological condition

Interventions

Intervention 1: Intervention group1: We inject 2.5 milligram in day Haloperidol in first group. Intervention 2: Intervention group2: We inject 25 milligram Quetiapine twice in day in second group.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Delirium detection more than 18 years

Exclusion criteria

Exclusion criteria: Dissatisfaction

Design outcomes

Primary

Measure	Time frame
Sedation. Timepoint: Every day to end of intervention. Method of measurement: Richmond agitation and sedation scale.;Illness severity. Timepoint: 1, 3, 7 and 10 day after start of intervention. Method of measurement: APACHE II.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026